Aptose Biosciences
Phase 1/2Aptose Biosciences is a clinical-stage biotechnology company committed to developing first-in-class targeted agents to treat life-threatening cancers.
Founded
2004
Focus
Small Molecules
About
Aptose Biosciences is a clinical-stage biotechnology company committed to developing first-in-class targeted agents to treat life-threatening cancers.
Funding History
4Total raised: $125M
PIPE$50MRA Capital ManagementMar 15, 2022
PIPE$40MRA Capital ManagementJun 15, 2020
Series B$25MUndisclosedJun 15, 2014
Series A$10MUndisclosedJun 15, 2011
Company Info
TypePrivate
Founded2004
LocationSan Diego, United States
StagePhase 1/2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile